RORα, a potential tumor suppressor and therapeutic target of breast cancer

Jun Du1, Ren Xu

  • 1Markey Cancer Center, University of Kentucky, Lexington, KY 40536, USA. ren.xu2010@uky.edu.

Insights

Retinoid orphan nuclear receptor alpha (RORα) acts as a tumor suppressor in breast cancer. Its down-regulation suggests RORα is a potential therapeutic target for treating breast cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Endocrinology

Background:

  • Nuclear receptors (NRs) play a role in breast cancer progression.
  • Many NRs have known ligands, but some are orphan receptors.
  • RORα, a member of the retinoid orphan nuclear receptor (ROR) subfamily, regulates cellular and pathological activities.

Purpose of the Study:

  • To investigate the function of RORα in breast cancer progression.
  • To explore RORα's potential as a therapeutic target.

Main Methods:

  • Analysis of RORα expression in breast cancer versus normal mammary tissue.
  • Evaluation of RORα's effect on malignant phenotypes in vitro and in vivo.
  • Examination of RORα's canonical and non-canonical pathways in regulating breast cancer cell functions.

Main Results:

  • RORα is frequently down-regulated or hypoactivated in breast cancer.
  • RORα expression suppresses malignant phenotypes in breast cancer cells.
  • RORα activity influences cell proliferation, apoptosis, and invasion via distinct pathways.

Conclusions:

  • RORα functions as a potent tumor suppressor in breast cancer.
  • RORα represents a promising therapeutic target for breast cancer treatment.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...